Skip to main content
Year archive

Karo Pharma AB — 2019 filings

All 63 regulatory filings released by Karo Pharma AB (KARO) in 2019, sourced directly from the official regulator.

63 Filings
2019 Period
2019 filings (63)
Filing Released Lang
Karo Pharma acquires product portfolio from LEO Pharma
M&A Activity
2019-12-23 English
Karo Pharma förvärvar produktportfölj av LEO Pharma
M&A Activity
2019-12-23 Swedish
Åsa Riisberg leaves the Board of Directors of Karo Pharma at her own request
Board/Management Information
2019-12-11 English
Åsa Riisberg lämnar Karo Pharmas styrelse på egen begäran
Board/Management Information
2019-12-11 Swedish
Major Shareholding Notification 2019
Major Shareholding Notification
2019-12-02 English
Karo Pharma avyttrar Hydrokortison Trimb till Evolan Pharma
M&A Activity
2019-11-27 Swedish
Karo Pharma divests Hydrokortison Trimb to Evolan Pharma
Regulatory Filings
2019-11-27 English
Förtydligande avseende ROR-gamma projektet
Legal Proceedings Report
2019-11-20 Swedish
Further clarification regarding the ROR-gamma project
Regulatory Filings
2019-11-20 English
Interim / Quarterly Report 2019
Interim / Quarterly Report 9M 2019
2019-11-15 Swedish
Interim / Quarterly Report 2019
Interim / Quarterly Report 9M 2019
2019-11-15 English
Termination of project regarding ROR-gamma
Legal Proceedings Report
2019-11-05 English
Projekt avseende ROR-gamma avslutas
Legal Proceedings Report
2019-11-05 Swedish
New number of shares and votes in Karo Pharma
Share Issue/Capital Change
2019-10-31 English
Nytt antal aktier och röster i Karo Pharma
Share Issue/Capital Change
2019-10-31 Swedish
Karo Pharmas företrädesemission fulltecknad
Capital/Financing Update
2019-10-21 Swedish
Karo Pharma’s rights issue fully subscribed
Capital/Financing Update
2019-10-21 English
Major Shareholding Notification 2019
Major Shareholding Notification
2019-10-08 English
Karo Pharma postpones publication of the interim report for the period January – September 2019
Report Publication Announcement
2019-10-08 English
Karo Pharma senarelägger publiceringen av delårsrapporten för perioden januari – september 2019
Report Publication Announcement
2019-10-08 Swedish
Karo Pharma publishes prospectus relating to the rights issue
Capital/Financing Update
2019-09-30 English
Karo Pharma offentliggör prospekt avseende företrädesemissionen
Capital/Financing Update
2019-09-30 Swedish
Karo Pharma beslutar om en fullt garanterad företrädesemission om cirka 2 miljarder kronor
Capital/Financing Update
2019-09-24 Swedish
Karo Pharma resolves on a fully guaranteed rights issue of approximately SEK 2 billion
Capital/Financing Update
2019-09-24 English
EXTRAORDINARY GENERAL MEETING IN KARO PHARMA AKTIEBOLAG ON 20 SEPTEMBER 2019
AGM Information
2019-09-20 English
EXTRA BOLAGSSTÄMMA I KARO PHARMA AKTIEBOLAG DEN 20 SEPTEMBER 2019
AGM Information
2019-09-20 Swedish
Karo Pharma’s planned rights issue is intended to amount to approximately SEK 2 billion
Capital/Financing Update
2019-09-19 English
Karo Pharmas planerade företrädesemission avses uppgå till cirka 2 miljarder kronor
Capital/Financing Update
2019-09-19 Swedish
Karo Pharma completes the acquisition of Trimb and carries out management changes
M&A Activity
2019-09-12 English
Karo Pharma slutför förvärvet av Trimb och genomför ledningsförändringar
Board/Management Information
2019-09-12 Swedish
Konkurrensverket i Sverige godkänner Karo Pharmas förvärv av Trimb och Karo Pharma fortsätter bolagets arbete med internalisering av marknadsföring och försäljning
M&A Activity
2019-09-04 Swedish
The Swedish Competition Authority approves Karo Pharma’s acquisition of Trimb and Karo Pharma continues the company’s efforts related to internalisation of sales and marketing
M&A Activity
2019-09-04 English
KALLELSE TILL EXTRA BOLAGSSTÄMMA I KARO PHARMA AKTIEBOLAG
AGM Information
2019-08-28 Swedish
NOTICE OF EXTRAORDINARY GENERAL MEETING IN KARO PHARMA AKTIEBOLAG
AGM Information
2019-08-28 English
Jon Johnsson appointed new CFO of Karo Pharma
Board/Management Information
2019-08-14 English
Jon Johnsson utsedd till ny CFO på Karo Pharma
Board/Management Information
2019-08-14 Swedish
Förtydligande avseende skrivning om företrädesemissionen i delårsrapporten som publicerades den 19 juli 2019
Share Issue/Capital Change
2019-07-19 Swedish
Clarification of the statement in the interim report published 19 July 2019 regarding the rights issue with pre-emptive rights
Share Issue/Capital Change
2019-07-19 English
Interim / Quarterly Report 2019
Interim / Quarterly Report H2 2019
2019-07-19 Swedish
Interim / Quarterly Report 2019
Interim / Quarterly Report H1 2019
2019-07-19 English
Karo Pharma förvärvar Trimb för 3 400 MSEK och avser genomföra en nyemission om cirka 1 500 MSEK
Capital/Financing Update
2019-06-21 Swedish
Karo Pharma acquires Trimb for MSEK 3,400 and intends to carry out a rights issue of approximately MSEK 1,500
Capital/Financing Update
2019-06-21 English
ÅRSSTÄMMA 2019 i KARO PHARMA AKTIEBOLAG
AGM Information
2019-05-16 Swedish
ANNUAL GENERAL MEETING 2019 IN KARO PHARMA AKTIEBOLAG
AGM Information
2019-05-16 English
Interim / Quarterly Report 2019
Interim / Quarterly Report Q1 2019
2019-04-26 Swedish
Interim / Quarterly Report 2019
Interim / Quarterly Report Q1 2019
2019-04-26 English
KALLELSE TILL ÅRSSTÄMMA I KARO PHARMA AKTIEBOLAG
AGM Information
2019-04-16 Swedish
NOTICE OF ANNUAL GENERAL MEETING IN KARO PHARMA AKTIEBOLAG
AGM Information
2019-04-16 English
Annual Report 2018
Annual Report FY 2018
2019-04-09 Swedish
Annual Report 2018
Annual Report FY 2018
2019-04-09 Swedish
Ändrat datum för Karo Pharmas årsstämma
Report Publication Announcement
2019-04-09 Swedish
New date for the annual general meeting of Karo Pharma
AGM Information
2019-04-09 English
Christoffer Lorenzen appointed CEO of Karo Pharma; Peter Blom resigning.
Board/Management Information
2019-04-03 English
Christoffer Lorenzen utsedd till VD för Karo Pharma; Peter Blom avgår.
Board/Management Information
2019-04-03 Swedish
BESLUT VID KARO PHARMAS EXTRA BOLAGSSTÄMMA DEN 14 FEBRUARI 2019
AGM Information
2019-02-14 Swedish
Interim / Quarterly Report 2018
Interim / Quarterly Report FY 2018
2019-02-14 Swedish
Interim / Quarterly Report 2018
Interim / Quarterly Report FY 2018
2019-02-14 English
Karo Intressenters förslag inför extra bolagsstämma den 14 februari 2019 i Karo Pharma
AGM Information
2019-02-11 Swedish
Karo Intressenter’s proposals ahead of the Extraordinary General Meeting in Karo Pharma on 14 February 2019
Board/Management Information
2019-02-11 English
Major Shareholding Notification 2019
Major Shareholding Notification
2019-01-25 English
KALLELSE TILL EXTRA BOLAGSSTÄMMA I KARO PHARMA AKTIEBOLAG
AGM Information
2019-01-22 Swedish
UTTALANDE FRÅN STYRELSEN FÖR KARO PHARMA AKTIEBOLAG MED ANLEDNING AV EQT VIII:S, GENOM KARO INTRESSENTER AB, HÖJDA OFFENTLIGA UPPKÖPSERBJUDANDE
M&A Activity
2019-01-02 Swedish
STATEMENT BY THE BOARD OF DIRECTORS OF KARO PHARMA AKTIEBOLAG IN RELATION TO THE INCREASED PUBLIC OFFER FROM EQT VIII, THROUGH KARO INTRESSENTER AB
M&A Activity
2019-01-02 English